Clinical Trials

Inclusion Criteria:

• Provision of signed and dated informed consent form.
• Stated willingness to comply with all study procedures and availability for the duration of the study.
• Male or female, greater than or equal to 18 years of age.
• Clinical diagnosis of heart failure with volume overload requiring admission to the hospital for diuresis.

Exclusion Criteria:

• An individual who meets any of the following criteria will be excluded from participation in this study:
  • Severe cardiac valvular disease;
  • Restrictive cardiomyopathy (amyloidosis, ericarditis/effusion);
  • Receiving intravenous: epoprostenol, milrinone, dobutamine, dopamine;
  • Cardiac assist devices (intra-aortic balloon pump, ventricular assist devices extracorporeal membrane oxygenation);
  • Congenital heart disease;
  • Carries the diagnosis of superior vena cava(SVC) syndrome;
  • Active infection or sepsis;
  • Pregnant or lactating;
  • Patients currently (or within 30 days)  participating in clinical trial with nvestigational drug or device;
  • Known psychiatric or neurologic disease or prisoners who are unable to consent;
  • Any other medical condition, which in the opinion of the investigator, would place the patient at undue risk from participating.